FindTrial
Sign In

Role Of Medicated Emesis And Mustard Oil In The Management Of Type 2 Diabetes Mellitus

A Comparative Clinical Study Of Vamana Karma Followed By Shamana Sneha (Sarshapa Taila) And Sarshapa Taila In The Management Of Sthool Pramehi With Special Reference To Type 2 Diabetes Mellitus - TYPE 2 DM

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/02/007967
Enrollment
30
Registered
2017-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Sthoola Pramehi(Type 2 Diabetes)

Interventions

Intervention1: Vamana Karma Followed By Shamana Sneha With SarShapa Taila: Classical Vamana Karma Internal Drug : Sarshapa Taila 20ml Once a Day Duration : 6 Weeks Follow up : 4 Weeks Control Interv

Sponsors

Govt Akhandanada Ayurveda College And Hospital Ahmedabad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient Having Classical Signs And Symptoms Of The Disease According To Ayurveda as Well As Modern Science Patients Of Prameha Having BMI Greater Than Or Equal 25 To Less Than Or Equal 35 Patient Of Niddm With Blood Sugar Level,FBS 126 To 220 Mg Per Dl Or PPBS 180 To 300mg Per Dl Age Group Of 20 To 60 Years Disease Chronicity Less Than 10 Year Patient Otherwise Healthy And Fit For Shodhana(Vamana) Poorvaka Shamanasneha And Shamanasneha As Per The Ayurvedic Classics

Exclusion criteria

Exclusion criteria: Patients Of Prameha Having BMI Less Than Or Equal 25 And Greater Than Or Equal 35 Patients Of Type1 Diabetes Or The Patients Of Type2 Diabetes Taking Insulin Patients Having Complications Of Diabetes Like Nephropathy Retinopathy Diabeticfoot Carbuncles Etc Age Less Than 20 To Greater Than 60 Years Patients Having Diabetes In Association With Other Endocrinopathies Like Phaeochromocytoma Acromegaly Cushings Syndrome Hyperthyroidism Etc Patients Having Drug Or Chemical Induced Type 2 Diabetes Like Glucocorticoids Induced Or Thyroid Hormone Induced Etc Patients With Genetic Syndromes Associated With Type 2 Diabetes Like Downs Syndrome Klinefelters Syndrome And Turners Syndrome Etc Patients Complicated With Any Cardiovascular Diseases Renal Diseases Carcinoma Or Any Other Disease Effecting Multiple Body Systems And Pregnant Women Etc

Design outcomes

Primary

MeasureTime frame
ASSESSMENT WILL BE DONE ON THE SPECIALLY DESIGNED PROFORMA OR ASESSING SIGN AND SYMPTOMS IN SCORING PATTERNTimepoint: 6 WEEKS—

Secondary

MeasureTime frame
ASSESSMENT WILL BE DONE ON THE SPECIALLY DESIGNED PROFORMA OR ASESSING SIGN AND SYMPTOMS IN SCORING PATTERNTimepoint: 6WEEKS—

Countries

India

Contacts

Public ContactFalgun P Patel

Govt Akhandananda Ayurved College And Hospital Bhadra Ahmedabad 380001

ram.ayu@gmail.com9925505758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026